Immuron (IMRN) Total Non-Current Liabilities (2017 - 2025)

Immuron (IMRN) recorded quarterly Total Non-Current Liabilities of $945.77 in Q3 2025, down 98.44% quarter-over-quarter from $60570.3 in Q2 2025, and down 33.18% on a YoY basis from $1415.5 in Q3 2024.

Immuron (IMRN) Total Non-Current Liabilities (2017 - 2025) Analysis & Trends

Immuron's Total Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $945.77 for Q3 2025.

  • In Q3 2025, Total Non-Current Liabilities fell 33.18% year-over-year to $945.77; the TTM figure through Sep 2025 stood at $945.77 (down 33.18% YoY), while the FY2025 annual figure was $945.77, down 33.18% from the prior year.
  • Total Non-Current Liabilities was $945.77 for Q3 2025 at Immuron, down from $60570.3 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $125667.1 in Q2 2022 to a low of $860.99 in Q4 2023.
  • Historically, Total Non-Current Liabilities has averaged $60271.1 across 5 years, with a median of $63476.0 in 2024.
  • The sharpest annual moves came in 2021 and 2023: Total Non-Current Liabilities jumped 8019.92% in 2021, then tumbled 99.25% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $26496.1 in 2021, then jumped by 335.05% to $115272.5 in 2022, then sank by 99.25% to $860.99 in 2023, then jumped by 7609.97% to $66381.8 in 2024, then plunged by 98.58% to $945.77 in 2025.
  • The last three Total Non-Current Liabilities figures came in at $945.77 (Q3 2025), $60570.3 (Q2 2025), and $66381.8 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Immuron 921.61 Mn 921.58 Mn - 945.77

Historic Data

Download Data
DateValue
Sep 2, 2025 945.77
Jun 30, 2025 60,570.25
Dec 31, 2024 66,381.83
Sep 9, 2024 1,415.46
Jun 30, 2024 93,282.28
Dec 31, 2023 860.99
Sep 28, 2023 99,768.61
Aug 30, 2023 1,522.07
Jun 30, 2023 101,729.14
Dec 31, 2022 115,272.50
Aug 31, 2022 122,009.86
Jun 30, 2022 125,667.13
Dec 31, 2021 26,496.13
Jun 30, 2021 27,872.92
Dec 31, 2020 326.31
Sep 1, 2020 41,839.00
Jun 30, 2020 27,422.14
Dec 31, 2019 418.39
Jun 30, 2019 10,493.07
Dec 31, 2017 1.83 Mn